Pages that link to "Q35699282"
Jump to navigation
Jump to search
The following pages link to Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer (Q35699282):
Displaying 50 items.
- Epigenetic drugs can stimulate metastasis through enhanced expression of the pro-metastatic Ezrin gene (Q33698044) (← links)
- DNA hypomethylation in cancer cells (Q33862334) (← links)
- S-Adenosylmethionine Inhibits the Growth of Cancer Cells by Reversing the Hypomethylation Status of c-myc and H-ras in Human Gastric Cancer and Colon Cancer (Q34394796) (← links)
- Distinct functional patterns of gene promoter hypomethylation and hypermethylation in cancer genomes (Q34412798) (← links)
- Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model. (Q34497982) (← links)
- DNA methylation regulates expression of VEGF-C, and S-adenosylmethionine is effective for VEGF-C methylation and for inhibiting cancer growth (Q34574257) (← links)
- Suppression of LFA-1 expression by spermine is associated with enhanced methylation of ITGAL, the LFA-1 promoter area (Q34589795) (← links)
- An integrated approach to uncover driver genes in breast cancer methylation genomes. (Q34665735) (← links)
- Demethylation of (Cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development. (Q34745299) (← links)
- Diagnostic markers of urothelial cancer based on DNA methylation analysis. (Q34756518) (← links)
- Activation of pro-uPA is critical for initial escape from the primary tumor and hematogenous dissemination of human carcinoma cells (Q35238060) (← links)
- DNA Methylation and Flavonoids in Genitourinary Cancers (Q35623184) (← links)
- Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression (Q35929823) (← links)
- Molecular marks for epigenetic identification of developmental and cancer stem cells (Q36001860) (← links)
- Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator (Q36302249) (← links)
- Radiation-induced hypomethylation triggers urokinase plasminogen activator transcription in meningioma cells (Q36629426) (← links)
- Small interfering RNA directed reversal of urokinase plasminogen activator demethylation inhibits prostate tumor growth and metastasis (Q36666169) (← links)
- Targeting uPA/uPAR in prostate cancer (Q36893941) (← links)
- Dissecting lipid raft facilitated cell signaling pathways in cancer (Q37047889) (← links)
- Prostatic preneoplasia and beyond (Q37047894) (← links)
- Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy (Q37135987) (← links)
- Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia (Q37137148) (← links)
- Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease (Q37224550) (← links)
- DNA methylation-mediated nucleosome dynamics and oncogenic Ras signaling: insights from FAS, FAS ligand and RASSF1A. (Q37273862) (← links)
- The polyamine and histamine metabolic interplay in cancer and chronic inflammation. (Q37341432) (← links)
- The urokinase plasminogen activator system: a target for anti-cancer therapy. (Q37387695) (← links)
- Promising tumor-associated antigens for future prostate cancer therapy. (Q37523602) (← links)
- Epigenetic DNA-(cytosine-5-carbon) modifications: 5-aza-2'-deoxycytidine and DNA-demethylation (Q37567870) (← links)
- DNA methylation or histone modification status in metastasis and angiogenesis-related genes: a new hypothesis on usage of DNMT inhibitors and S-adenosylmethionine for genome stability (Q37785857) (← links)
- Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1. (Q37801943) (← links)
- Aβ-degrading enzymes: potential for treatment of Alzheimer disease. (Q37946240) (← links)
- DNA hypomethylation and hemimethylation in cancer (Q38041519) (← links)
- Global DNA hypomethylation in cancer: review of validated methods and clinical significance (Q38054435) (← links)
- Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer (Q38132176) (← links)
- Potential involvement of mi-RNA 574-3p in progression of prostate cancer: A bioinformatic study (Q38653295) (← links)
- The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies (Q38669212) (← links)
- Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells (Q38841614) (← links)
- Carbon-ion radiation enhances migration ability and invasiveness of the pancreatic cancer cell, PANC-1, in vitro (Q39428092) (← links)
- Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer (Q39514729) (← links)
- Inhibition of histone deacetylase activity down-regulates urokinase plasminogen activator and matrix metalloproteinase-9 expression in gastric cancer (Q39691186) (← links)
- S-adenosylmethionine modifies cocaine-induced DNA methylation and increases locomotor sensitization in mice (Q48007297) (← links)
- Methyl donor S-adenosylmethionine (SAM) supplementation attenuates breast cancer growth, invasion, and metastasis in vivo; therapeutic and chemopreventive applications (Q49775755) (← links)
- Treatment of prostate cancer cells with S-adenosylmethionine leads to genome-wide alterations in transcription profiles (Q50479861) (← links)
- S-adenosyl- l -methionine analogs as enhanced methyl donors: Towards novel epigenetic regulators (Q56782244) (← links)
- The Methylation Status of the Epigenome: Its Emerging Role in the Regulation of Tumor Angiogenesis and Tumor Growth, and Potential for Drug Targeting (Q58789495) (← links)
- Expression of urokinase-type plasminogen activator system in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy (Q81160536) (← links)
- Current world literature. Ageing: biology and nutrition (Q82841658) (← links)
- Inhibition of angiogenesis by S-adenosylmethionine (Q83778661) (← links)
- Enzymatic control of plasmonic coupling and surface enhanced Raman scattering transduction for sensitive detection of DNA demethylation (Q84997748) (← links)
- Retraction: Demethylation-Linked Activation of Urokinase Plasminogen Activator Is Involved in Progression of Prostate Cancer (Q89121029) (← links)